Jing Rong Cui
Founder at Blossomhill Therapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Yi Shan Li | M | 59 |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | 11 years |
| Carl Gordon | M | 59 |
Blossomhill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | 4 years |
| Scott Lipman | M | - | 4 years | |
| Bihua Chen | F | 55 |
Blossomhill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | - |
| George Lee | M | 73 |
Blossomhill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | - |
| Gavin Hirst | M | - | 4 years | |
| Naresh K. Nayyar | M | - | 6 years | |
| Miriam Cruz | F | - | 6 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Athena Countouriotis | M | 52 | - | |
| Brian Baker | M | 57 | 4 years | |
| Garry Nicholson | M | 69 | 2 years | |
| Clarence Machado | M | 60 | 3 years | |
| Jacob Chacko | M | 45 | 3 years | |
| Sheila Gujrathi | M | 53 | 4 years | |
| Carol Gallagher | M | 59 | 3 years | |
| Simeon George | M | 46 | 5 years | |
| Hong Bo Lu | M | 53 | 2 years | |
| Annette C. North | F | 58 | 3 years | |
| Robert J. Adelman | M | 61 | - | |
| Lewis J. Shuster | M | 68 | - | |
| Dana Hu-Lowe | M | - | 2 years | |
| Brett Zbar | M | 51 | 1 years | |
| Mohammad Hirmand | M | 54 | 3 years | |
| Yuelie Lu | M | 66 | 1 years | |
| Kenneth Fong | M | - | - | |
| Siegfried Reich | M | 64 | 2 years | |
| Homa Yeganegi | F | - | - | |
| Jakob Loven | M | 46 | 1 years | |
| Yi Larson | F | 44 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 29 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jing Rong Cui
- Personal Network
